Product Information

LANSOPRAZOLE DR 30 MG ODT is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $2.1807 per EA under NDC 68382077277. Its NADAC has been published 387 times since Jan 30, 2019.

The High Outlier badge above means this manufacturer's average price in the LANSOPRAZOLE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LANSOPRAZOLE DR 30 MG ODT

LANSOPRAZOLE
$2.1807per EA
High Outlier

Strength

30 mg/1

NDC

68382077277

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LANSOPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA200816

On Market Since

11/30/2018

Pharmacological Classes

Inhibition Gastric Acid Secretion
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for LANSOPRAZOLE DR 30 MG ODT has been published 387 times since Jan 30, 2019, and over the history we have for it it has declined 80.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2.1807 per EA
All-time high$11.2227 (Jun 12, 2019)
All-time low$1.8384 (Apr 22, 2026)
52-week high$3.1027
52-week low$1.8384
Median price$4.4740
Average price$5.1271
Largest weekly change+43.5% (Sep 22, 2021)
Weeks tracked387
Tracking sinceJan 30, 2019

Price History

1W

0.0%

1M

+5.3%

3M

+12.3%

6M

-12.2%

1Y

-29.7%

3Y

-42.7%

5Y

-59.9%

All

-80.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the LANSOPRAZOLE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of LANSOPRAZOLE DR 30 MG ODT?

The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG ODT, manufactured by Zydus Pharmaceuticals (USA) Inc., is $2.1807 per EA (NDC 68382077277), effective Jun 24, 2026.

How has the price of LANSOPRAZOLE DR 30 MG ODT changed over time?

Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG ODT has declined 80.6%. It has been tracked across 387 weekly CMS publications since Jan 30, 2019.

What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG ODT?

Since Jan 30, 2019, the NADAC for LANSOPRAZOLE DR 30 MG ODT has ranged from a low of $1.8384 (Apr 22, 2026) to a high of $11.2227 (Jun 12, 2019), with a median of $4.4740 per EA.

Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG ODT?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LANSOPRAZOLE DR 30 MG ODT, so no direct lower-cost alternative is listed.

Who manufactures LANSOPRAZOLE DR 30 MG ODT?

LANSOPRAZOLE DR 30 MG ODT (NDC 68382077277) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.